7Baggers

OrthoPediatrics Corp Quarterly Income Statements Chart

Quarterly
 | 
Annual
 
 Gross Profit  
 Operating Profit  
 Net Income  
20200930 20201231 20210331 20210630 20210930 20211231 20220331 20220630 20220930 20221231 20230331 20230630 20230930 20231231 20240331 20240630 20240930 20241231 20250331 20250630 -16.07-7.491.19.6818.2726.8535.4444.02Milllion

OrthoPediatrics Corp Quarterly Income Statements Table

Quarterly
 | 
Annual
 
Unit: USD2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 
                                  
  net revenue61,082,000 52,411,000 52,667,000 54,573,000 52,802,000 44,685,000 37,613,000 39,972,000 39,559,000 31,588,000 30,994,000 34,950,000 32,928,000 23,417,000 24,813,000 25,079,000 26,695,000 21,462,000 18,924,000 22,205,000 13,593,000 16,356,000 18,952,000 20,744,000 18,200,000 14,656,000 14,568,000 15,820,000 15,077,000 12,094,000 11,681,000 12,375,000 
  cost of revenue17,063,000 14,149,000 17,102,000 14,513,000 12,003,000 12,511,000 10,899,000 9,019,000 9,534,000 8,027,000 9,770,000 9,061,000 7,947,000 4,851,000 6,732,000 6,525,000 6,252,000 5,137,000 3,806,000 4,566,000 3,532,000 4,143,000 4,502,000 4,849,000 4,581,000 4,001,000 4,054,000 3,843,000 3,807,000 3,175,000 2,849,000 2,884,000 
  gross profit44,019,000 38,262,000 35,565,000 40,060,000 40,799,000 32,174,000 26,714,000 30,953,000 30,025,000 23,561,000 21,224,000 25,889,000 24,981,000 18,566,000 18,081,000 18,554,000 20,443,000 16,325,000 15,118,000 17,639,000 10,061,000 12,213,000 14,450,000 15,895,000 13,619,000 10,655,000 10,514,000 11,977,000 11,270,000 8,919,000 8,832,000 9,491,000 
  yoy7.89% 18.92% 33.13% 29.42% 35.88% 36.56% 25.87% 19.56% 20.19% 26.90% 17.38% 39.53% 22.20% 13.73% 19.60% 5.19% 103.19% 33.67% 4.62% 10.97% -26.13% 14.62% 37.44% 32.71% 20.84% 19.46% 19.04% 26.19%     
  qoq15.05% 7.58% -11.22% -1.81% 26.81% 20.44% -13.69% 3.09% 27.44% 11.01% -18.02% 3.63% 34.55% 2.68% -2.55% -9.24% 25.23% 7.98% -14.29% 75.32% -17.62% -15.48% -9.09% 16.71% 27.82% 1.34% -12.22% 6.27% 26.36% 0.99% -6.94%  
  gross margin %                                
  operating expenses:                                
  sales and marketing19,103,000 16,572,000 16,784,000 16,750,000 16,593,000 14,169,000 12,439,000 13,582,000 13,165,000 12,216,000 10,945,000 11,919,000 12,431,000 9,758,000 9,986,000 9,862,000 10,876,000 8,949,000 9,433,000 9,237,000 5,620,000 7,564,000 8,360,000 8,771,000 7,606,000 6,547,000 6,558,000 7,150,000 6,776,000 6,079,000 5,405,000 5,633,000 
  general and administrative30,443,000 30,280,000 24,431,000 26,299,000 27,329,000 24,730,000 19,594,000 18,507,000 19,654,000 17,666,000 16,554,000 15,116,000 14,546,000 13,167,000 11,898,000 11,034,000 11,088,000 12,041,000 10,036,000 9,823,000 10,577,000 7,881,000 7,216,000 7,267,000 6,569,000 5,612,000 4,545,000 4,877,000 5,499,000 6,017,000 6,690,000 3,487,000 
  restructuring2,971,000 40,000                               
  research and development2,159,000 2,351,000 2,916,000 2,577,000 2,543,000 2,998,000 2,747,000 2,387,000 2,792,000 2,270,000 2,034,000 2,206,000 1,747,000 2,027,000 1,608,000 1,302,000 1,325,000 1,308,000 2,050,000 1,077,000 881,000 1,265,000 1,905,000 1,396,000 1,234,000 1,213,000 1,277,000 1,122,000 1,115,000 1,218,000 941,000 1,127,000 
  total operating expenses54,676,000 49,243,000 49,620,000 45,626,000 46,465,000 41,897,000 34,780,000 35,461,000 35,611,000 32,152,000 29,533,000 32,850,000 28,724,000 24,952,000 23,642,000 22,198,000 23,289,000 22,298,000 27,861,000 20,137,000 17,078,000 16,710,000 17,481,000 17,434,000 15,409,000 13,372,000 12,380,000 13,149,000 13,390,000 13,314,000 13,036,000 10,247,000 
  operating income-10,657,000 -10,981,000 -14,055,000 -5,566,000 -5,666,000 -9,723,000 -8,066,000 -4,508,000 -5,586,000 -8,591,000 -8,309,000 -6,961,000 -3,743,000 -6,386,000 -5,561,000 -3,644,000 -2,846,000 -5,973,000 -12,743,000 -2,498,000 -7,017,000 -4,497,000 -3,031,000 -1,539,000 -1,790,000 -2,717,000 -1,866,000 -1,172,000 -2,120,000 -4,395,000 -4,204,000 -756,000 
  yoy88.09% 12.94% 74.25% 23.47% 1.43% 13.18% -2.92% -35.24% 49.24% 34.53% 49.42% 91.03% 31.52% 6.91% -56.36% 45.88% -59.44% 32.82% 320.42% 62.31% 292.01% 65.51% 62.43% 31.31% -15.57% -38.18% -55.61% 55.03%     
  qoq-2.95% -21.87% 152.52% -1.76% -41.73% 20.54% 78.93% -19.30% -34.98% 3.39% 19.37% 85.97% -41.39% 14.84% 52.61% 28.04% -52.35% -53.13% 410.13% -64.40% 56.04% 48.37% 96.95% -14.02% -34.12% 45.61% 59.22% -44.72% -51.76% 4.54% 456.08%  
  operating margin %                                
  other income:                                
  interest expense1,116,000 1,126,000 325,500 404,000 261,000  26,250 21,000 294,000  -61,000 708,000 1,212,000 566,000 396,000 542,000 581,000 728,000 624,000 1,010,000 1,399,000 379,000 1,306,000 1,297,000 632,000 303,000 533,000 608,000 562,000 552,000 633,000 761,000 
  other income-4,709,000 -1,644,000 1,035,000 -63,000 120,000 -24,000    -331,000 128,000 945,000 827,000 -105,000 -281,000 -267,000 -375,000 -160,000 -332,000 122,000 121,000 69,000 -8,000 41,000 37,000  69,000 85,000 10,000 53,000 8,000 20,000 
  total other income-3,593,000 -518,000 1,141,250 3,571,000 381,000 613,000 -1,163,000 -766,000                         
  net income before income taxes-7,064,000 -10,463,000                               
  income tax charge49,000 196,000                               
  net income-7,113,000 -10,659,000 -16,069,000 -7,919,000 -6,029,000 -7,805,000 -6,691,000 -4,591,000 -2,886,000 -6,806,000 -7,848,000 18,539,000 -333,000 -9,100,000 72,000 -2,197,000 -3,756,000 -10,379,000 -14,013,000 -4,539,000 -9,447,000 -4,945,000 -5,429,000 -2,664,000 -2,618,000 -3,020,000 -2,468,000 -1,865,000 -2,692,000 -5,000,000 -4,845,000 -1,537,000 
  yoy17.98% 36.57% 140.16% 72.49% 108.91% 14.68% -14.74% -124.76% 766.67% -25.21% -11000.00% -943.83% -91.13% -12.32% -100.51% -51.60% -60.24% 109.89% 158.11% 70.38% 260.85% 63.74% 119.98% 42.84% -2.75% -39.60% -49.06% 21.34%     
  qoq-33.27% -33.67% 102.92% 31.35% -22.75% 16.65% 45.74% 59.08% -57.60% -13.28% -142.33% -5667.27% -96.34% -12738.89% -103.28% -41.51% -63.81% -25.93% 208.72% -51.95% 91.04% -8.92% 103.79% 1.76% -13.31% 22.37% 32.33% -30.72% -46.16% 3.20% 215.22%  
  net income margin %                                
  weighted-average shares outstanding                                
  basic and diluted23,460,144,000 23,230,871,000  23,171,249,000 23,145,064,000 22,820,779,000                           
  net income per share        -0.13 -0.3   -0.02 -0.47 0.01 -0.11 -0.19 -0.54 -0.75 -0.24 -0.54 -0.3 -0.37 -0.18 -0.18 -0.21 -0.19 -0.15 -0.21 -0.41 -1.04 -1.7 
  basic and diluted-0.3 -0.46 -0.235 -0.34 -0.26 -0.34                           
  tradename impairment                                
  loss on early extinguishment of debt   3,230,000                             
  fair value adjustment of contingent consideration      -6,000  -2,304,000 -670,000 -480,000 -23,010,000 -5,010,000 2,570,000 -5,510,000 -1,430,000 990,000 4,150,000 1,701,000 909,000 910,000            
  income before income taxes  -6,380,000 -9,137,000 -6,047,000 -10,336,000 -6,903,000 -3,742,000 -3,287,000 -7,380,000 -7,896,000 14,396,000 -772,000 -9,417,000 -166,000 -2,489,000 -4,042,000 -10,691,000               
  benefit from income taxes  -941,750 -1,218,000 -18,000 -2,531,000 -212,000 849,000 -401,000 -574,000 -48,000 -4,143,000 -439,000 -317,000 -238,000 -292,000 -286,000 -312,000               
  interest income     637,000    -210,000                       
  trademark impairment       985,000    3,609,000                     
  other incomes:                                
  other (income) loss      -351,750 -787,000 -289,000                        
  weighted-average shares outstanding                                
  basic  23,077,704,000    22,675,477,000 22,762,823,000   20,704,556,000 21,150,219,000                     
  diluted  23,077,704,000    22,675,477,000 22,762,823,000   20,947,727,000 21,295,323,000                     
  net income per share        -0.13 -0.3   -0.02 -0.47 0.01 -0.11 -0.19 -0.54 -0.75 -0.24 -0.54 -0.3 -0.37 -0.18 -0.18 -0.21 -0.19 -0.15 -0.21 -0.41 -1.04 -1.7 
  basic      -0.29 -0.2   -0.38 0.88                     
  diluted      -0.29 -0.2   -0.37 0.87                     
  total other incomes        -2,299,000 -1,211,000 -413,000 -21,357,000 -2,971,000 3,031,000 -5,395,000 -1,155,000 1,196,000 4,718,000 1,993,000 2,041,000 2,430,000 448,000 1,298,000 1,338,000 669,000 303,000 602,000 693,000 572,000 605,000 641,000 781,000 
  weighted-average common stock - basic and diluted        22,704,723,000 22,506,024,000   19,792,286,000 19,366,911,000  19,291,374,000 19,275,779,000 19,200,231,000  19,112,797,000 17,549,118,000 16,423,853,000  14,639,020,000 14,451,979,000 14,367,056,000  12,624,858,000 12,549,226,000    
  net income per share        -0.13 -0.3   -0.02 -0.47 0.01 -0.11 -0.19 -0.54 -0.75 -0.24 -0.54 -0.3 -0.37 -0.18 -0.18 -0.21 -0.19 -0.15 -0.21 -0.41 -1.04 -1.7 
  other incomes                                
  net income from continuing operations                  -14,013,000 -4,539,000 -9,447,000  -4,329,000 -2,877,000 -2,459,000        
  net income from discontinued operations                        -159,000        
  net gain from discontinued operations                      13,500 213,000         
  net income attributable to common stockholders                      -5,429,000 -2,664,000 -2,618,000  -2,468,000 -1,865,000 -2,692,000 -5,000,000 -15,079,000 -3,021,000 
  weighted-average common shares - basic and diluted              19,268,255,000    18,056,828,000    14,624,194,000    12,567,387,000   12,073,776,000 4,017,330,000 1,773,385,000 

We provide you with 20 years income statements for OrthoPediatrics Corp stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as earnings, sales and marketing expenses, research and development costs, profits, and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of OrthoPediatrics Corp stock. Explore the full financial landscape of OrthoPediatrics Corp stock with our expertly curated income statements.

The information provided in this report about OrthoPediatrics Corp stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.